HKSE - Delayed Quote HKD

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)

1.820 -0.020 (-1.09%)
At close: 3:17 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Hong Zhang Executive Chairman, CEO & Compliance Officer 673.88k -- 1955
Mr. Bao Gang Zhao CFO & Executive Director 474.85k -- 1967
Mr. Xiang Fu Xu Deputy Technical GM & Executive Director 282.31k -- 1971
Mr. Guo Wen Wu Deputy Sales Director & Executive Director 196.86k -- 1965
Mr. Xiao Guang Zhang GM & Executive Director 517.04k -- 1964
Mr. Yi Zhang Executive GM & Executive Director 432.67k -- 1982
Mr. Sai Cheong Mok ACCA, C.P.A., CPA, FCCA Company Secretary -- -- 1980

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Grand Plaza, Office Tower Two
11th floor, Room 1101- 2 625 & 639 Nathan Road Mong Kok
Kowloon
Hong Kong
86 435 821 8333 https://www.jlchanglong.com
Sector: 
Healthcare
Full Time Employees: 
848

Description

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers Edaravone injection, compound brain comfort capsules, haikun kidney hi capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine glucosa tablets, prostate laurel yellow tablets, tranquility tablets, pharyngitis tablets, and low back pain capsules. The company markets its products under the Changlong and Qing Tong brands. It also engages in the manufacture and distribution of beverages and prepackaged food. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Corporate Governance

Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jun 08, 2023
    Ex-Dividend Date

Upcoming Events

Apr 25, 2024
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Earnings Call

Related Tickers